An open-label, randomized, single center study evaluating the efficacy and safety of Ivabradine or Metoprolol, or Ivabradine plus Metoprolol combination in patients with conduction abnormalities or Left Ventricular systolic dysfunction undergoing coronary artery bypass grafting or valvular replacement.
Phase of Trial: Phase III
Latest Information Update: 01 Jan 2013
At a glance
- Drugs Ivabradine; Metoprolol
- Indications Bundle branch block; Conduction disorders; Heart block; Left ventricular dysfunction
- Focus Adverse reactions; Therapeutic Use
- 05 Nov 2010 New trial record.